Lymphomatous Meningitis: Symptoms, Prognosis, and Treatment

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the spinal cord and brain. This tissue, the "meninges," protects the nervous system and when it is compromised by LM, the flow of cerebrospinal fluid [CSF] is compromised, resulting in a rapid deterioration of the central nervous system. It should be noted that "meningitis" is a somewhat inaccurate name as it implies inflammation which is not always present.

Incidence

Fewer than 10% of cancer patients with cancer are diagnosed with LM; because LM is a peripheral cancer, often diagnosed by autopsy, it is difficult to state incidence rates with high accuracy. It is known that LM incidence is on the rise, possibly because improved treatment of primary cancers results in more patients who are vulnerable to this condition which is especially prevalent in recurring cancers.

LM is of particular interest to lymphoma patients as some lymphoma patients carry a higher risk for LM than other cancer patients.

Symptoms

Symptoms are generally the result of the obstructed flow CSF by inflammation and/or tumors. They vary widely and do not always raise a "red flag" for LM. Symptoms may include:

  • Pain and seizures (the most common patient-reported symptoms)
  • Headaches (usually associated with nausea, vomiting, lightheadedness)
  • Gait difficulties from weakness or ataxia
  • Memory problems
  • Incontinence
  • Sensory abnormalities

Prognosis

It is generally believed that LM is underdiagnosed because of widely varying symptoms and the fact that it is preceded by other cancers, often in the later stages. If not detected, it usually results in death within four to six weeks. It is not often cured but it is treatable.

Treatment

Both radiation therapy and chemotherapy are indicated for lymphomatous meningitis; sometimes a combination of the two is employed.

In the case of chemotherapy, cytarabine is the first choice. DepoCyt®, a liposome-encapsulated time-release form of cytarabine, is a favored treatment because it is only administered once every two weeks as opposed to multiple times per week for the non-encapsulated form.

 

Sources

Photo: Pexels

More Articles

More Articles

It is nearly impossible to talk about a survival rate for...

Lymphosarcoma is a malignant tumor (or tumors) derived from lymphoid tissue (lymph nodes, tonsils, thymus, spleen, etc.). It is an illness that...

Diffuse Large B-Cell Lymphoma (DLBCL) is an aggressive Non-Hodgkin’s Lymphoma (NHL) that occurs in B-cells....

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

A lymphoma diagnosis is not difficult to determine once a patient and doctor begin to look for signs of cancer...

The lymphatic system, or lymph system, defends the body from foreign invasion by disease causing agents such as viruses, bacteria, or fungi. The...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphoma is a general term for cancer in the lymph system. The lymph system is made up of many cells and organs, including the lymph nodes, thymus...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...

While the average lifespan for hamsters is only about 2.5 years, and they are therefore less prone to long-term illnesses, it is possible for a...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

Lymphoma is the most common cancer in dogs, and the subtype most dogs present with is...